James M. Mock, Chief Financial Officer at Moderna, Inc. (MRNA), sold 715 shares at $60.12 ($43K) on 2024-10-07, disclosed to the SEC on 2024-10-08.
Open-market sale of $43k MRNA by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| MRNA | SELL | 2024-08-30 | $13K | — | Filing → |
| MRNA | SELL | 2024-08-29 | $210K | — | Filing → |
| MRNA | SELL | 2024-07-09 | $163K | — | Filing → |